Anti-obesity drugs raise men's testosterone levels

Anti-obesity medications can normalize testosterone levels in men, according to a new study presented today at the Endocrine Society's annual meeting. This finding suggests a potential benefit for men with obesity or type 2 diabetes. The study analyzed 110 men using weight-loss medications like semaglutide, dulaglutide, or tirzepatide. Researchers found that the proportion of men with normal testosterone levels increased from 53% to 77% after treatment and weight loss. Testosterone impacts male sexual function, bone mass, and muscle strength. The study highlights a direct correlation between anti-obesity medications and improved testosterone levels, offering a new consideration for doctors and patients.